Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2002
01/17/2002WO2001010468A3 Drug-carrier complexes and methods of use thereof
01/17/2002WO2001007613A3 Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
01/17/2002WO2001007471A3 Cell cycle and proliferation proteins
01/17/2002WO2001000669A3 A bap28 gene and protein
01/17/2002WO2000079009A3 Improved primers and methods for the detection and discrimination of nucleic acids
01/17/2002WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides
01/17/2002WO2000078953A3 Human transport proteins
01/17/2002WO2000078952A3 Human rna metabolism proteins (rmep)
01/17/2002WO2000070023A9 Novel fab fragment libraries and methods for their use
01/17/2002WO2000063391A3 Nucleic acid sequences to proteins involved in tocopherol synthesis
01/17/2002WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
01/17/2002WO2000025798A8 Treatment of parkinson's disease with oligonucleotides
01/17/2002US20020007501 Protein; for use in the generation of stress, insect and disease resistant plants
01/17/2002US20020007500 Removing expression vector from sexually reproducing cells; provide transformed cells, incubate with suppression agent, provide automatic transgenic insert, remove insert
01/17/2002US20020007499 DNA sequence; transgenic plants; enzyme preferentially produces erucic acid triglycerides such as trierucin; vegetable oil
01/17/2002US20020007498 P2x7 receptor-deficient non-human animals and uses thereof
01/17/2002US20020007073 Capable of producing complexes with polynucleotides (DNA, RNA, antisense oligonucleotides, ribozymes); suitable as vectors for transfection
01/17/2002US20020007054 Method for purifying nucleic acid and apparatus using the same
01/17/2002US20020007053 Genetic engineering; herbicide tolerant transgenic plants; efficiency
01/17/2002US20020007052 Point mutations; genetic engineering; hybridization
01/17/2002US20020007051 Producing population of hybrid nucleic acid molecules via mixing populations of nucleic acid molecules containing multiple recombination sites; genetic engineering; gene expression
01/17/2002US20020007046 Polypeptides for use in the diagnosis, prevention and treatment of cancer and immunological defects
01/17/2002US20020006912 Suppression of nuclear factor-kappab dependent processes using oligonucleotides
01/17/2002US20020006903 Genetic engineering
01/17/2002US20020006672 Generating preferential matrix; embedded particles in matrix, form transfer aggregations, heat, dissolve transfer aggregations, apply to matrix, vaporize, link transfer aggregation in matrix, allow gelation repeat in another
01/17/2002US20020006665 Ketogulonigenium endogenous plasmids
01/17/2002US20020006664 Arrayed transfection method and uses related thereto
01/17/2002US20020006661 Controlling gene expression in living cells
01/17/2002US20020006657 Nucleic acids which encode insect acetylcholine receptor subunits
01/17/2002US20020006652 Nucleic acids encoding polypeptides having haloperoxidase activity
01/17/2002US20020006651 To convert ethyl 4-chloroacetoacetate using NADPH as a coenzyme to produce ethyl (S)-4-chloro-3-hydroxybutyrate; substrate specificity, no activity to ethyl acetoacetate, specified optimal pH and temperature; enzyme from candida
01/17/2002US20020006645 Producing (S)-4-hydroxy-2-ketoglutaric acid and compounds which are formed by biosynthesis from this precursor using recombinant microorganism carrying a recombinant DNA harboring this acid aldolase gene, sugar and glyoxylic acid
01/17/2002US20020006641 Increasing production of proteins in gram-positive microorganisms
01/17/2002US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies
01/17/2002US20020006637 Particle-mediated transformation of animal tissue cells
01/17/2002US20020006622 Generating a molecular profile of genomic DNA by hybridization of labeled nucleic acid representing the genomic DNA to immobilized nucleic acid probes, e.g., arrays or biochips.
01/17/2002US20020006618 Detecting modulators of enzyme activities; mix nuxleotide sequences and modulator, detect complex between modulator and enzymatic polypeptides,
01/17/2002US20020006617 Nucleic acid detection methods using universal priming
01/17/2002US20020006615 Methods for the storage and synthesis of nucleic acids
01/17/2002US20020006610 Detection of enterovirus in a sample; provide sample, inoculate sample, monitor sample for presence of enterovirus
01/17/2002US20020006604 Solid support for the detection of preferential compounds in sample
01/17/2002US20020006412 An adenovirus particulate comprising adenovirus particles complexed to an insoluble micro-platform selected from polymeric fiber or microbead; adenovirus particulate comprises a cell binding ligand complexed to microplatform
01/17/2002US20020006411 Vaccines expressed in plants
01/17/2002US20020006408 Vaccines against eimeria mediated disorder
01/17/2002US20020006407 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
01/17/2002US20020006400 Recombinant human CLN2 protein and methods of its production and use
01/17/2002US20020006398 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
01/17/2002US20020006397 Delivering a cytotoxic agent which is one or more of herpes simplex virus thymidine kinase (HSV-tk), gancicolvir, or a rejection antigen, into a antigenic biniding protein APBP molecule to induce lysis of target cell
01/17/2002US20020006396 Method of treating portal hypertension
01/17/2002US20020006395 Defective adenoviruses including a therapeutic gene and an immunoprotective gene
01/17/2002US20020006391 Genetic engineering
01/17/2002US20020006379 Diagnosis of tissue damage, cancer
01/17/2002EP1144666A3 Replication deficient baculovirus expression system
01/17/2002DE10032379A1 Promotoren zur Genexpression in Karyopsen von Pflanzen Promoters for gene expression in caryopses of plants
01/17/2002DE10032173A1 Neue für das plsC-Gen kodierende Nukleotidsequenzen New coding for the plsC gene nucleotide sequences
01/17/2002CA2658217A1 Expression system
01/17/2002CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases
01/17/2002CA2416219A1 Artificial antibody polypeptides
01/17/2002CA2416203A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants
01/17/2002CA2415967A1 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
01/17/2002CA2415897A1 Real-time sequence determination
01/17/2002CA2415808A1 Transporters and ion channels
01/17/2002CA2415790A1 Sinapolyglucose : malate sinapolyltransferase forms malate conjugates from benozic acid glucosides
01/17/2002CA2415767A1 High fidelity polymerases and uses thereof
01/17/2002CA2415763A1 Production of chimeric human papillomavirus
01/17/2002CA2415639A1 Distinguishing molecular forms
01/17/2002CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer
01/17/2002CA2415484A1 Human myeloma cell line
01/17/2002CA2415483A1 Antisense compositions targeted to .beta.1 adrenoceptor-specific mrna and methods of use
01/17/2002CA2415478A1 Compounds targeted to cellular locations
01/17/2002CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors
01/17/2002CA2415382A1 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
01/17/2002CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
01/17/2002CA2415253A1 Bio-probes and use thereof
01/17/2002CA2415179A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
01/17/2002CA2415127A1 Down syndrome critical region 1-like 1 proteins
01/17/2002CA2414986A1 Diagnostic method for the identification of foetal dna in a maternal sample
01/17/2002CA2414572A1 Method of identifying conformation-sensitive binding peptides and uses thereof
01/17/2002CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002CA2414460A1 Fimh adhesin proteins and methods of use
01/17/2002CA2414443A1 Method and system for modeling biological systems
01/17/2002CA2414387A1 Drug metabolizing enzymes
01/17/2002CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
01/17/2002CA2414272A1 Bifunctional molecules and vectors complexed therewith for targeted gene delivery
01/17/2002CA2414219A1 Lipid metabolism molecules
01/17/2002CA2413810A1 Aminoacyl trna synthetases
01/17/2002CA2413045A1 Expression system
01/17/2002CA2412764A1 Stimulation of cellular regeneration and differentiation in the inner ear
01/17/2002CA2412581A1 Transforming growth factor beta (tgf-.beta.) blocking agent-treated stem cell composition and method
01/17/2002CA2351110A1 Helicobacter felis vaccine
01/16/2002EP1172654A1 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors
01/16/2002EP1172446A2 Nucleic acid mediated electron transfer
01/16/2002EP1172445A1 A method for direct genetic analysis of target cells by using fluorescence probes
01/16/2002EP1172441A1 A promoter derived from phytosulfokine precursor gene
01/16/2002EP1172440A1 Novel mannose isomerase and dna encoding the enzyme
01/16/2002EP1172439A1 Thermostable enzyme having aminotransferase activity and gene encoding the same
01/16/2002EP1172438A1 Polyhyroxyalkanoate synthase and gene encoding the same enzyme
01/16/2002EP1172436A1 Ceramidase gene
01/16/2002EP1172374A1 Crystal structure (3 A resolution) of the 30S ribosome and its use
01/16/2002EP1171638A1 Methods for identifying a protease inhibitor